Penumbra (PEN) FCF Margin (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Penumbra | 12.52 Bn | 11.91 Bn | 253.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -191.00 |
| Dec 31, 2025 | -271.00 |
| Sep 30, 2025 | 1,553.00 |
| Jun 30, 2025 | -230.00 |
| Mar 31, 2025 | -966.00 |
| Dec 31, 2024 | 366.00 |
| Sep 30, 2024 | 1,091.00 |
| Jun 30, 2024 | -562.00 |
| Mar 31, 2024 | -473.00 |
| Dec 31, 2023 | 873.00 |
| Sep 30, 2023 | 19.00 |
| Jun 30, 2023 | 364.00 |
| Mar 31, 2023 | 483.00 |
| Dec 31, 2022 | 801.00 |
| Sep 30, 2022 | 1,211.00 |
| Jun 30, 2022 | -1,648.00 |
| Mar 31, 2022 | 791.00 |
| Dec 31, 2021 | -3,036.00 |
| Sep 30, 2021 | 1,963.00 |
| Jun 30, 2021 | 796.00 |
| Mar 31, 2021 | -860.00 |
| Dec 31, 2020 | -898.00 |
| Sep 30, 2020 | 3,483.00 |
| Jun 30, 2020 | -1,534.00 |
| Mar 31, 2020 | -1,498.00 |
| Dec 31, 2019 | -1,134.00 |
| Sep 30, 2019 | 1,354.00 |
| Jun 30, 2019 | 338.00 |
| Mar 31, 2019 | -880.00 |
| Dec 31, 2018 | -260.00 |
| Sep 30, 2018 | 964.00 |
| Jun 30, 2018 | -1,054.00 |
| Mar 31, 2018 | 1,692.00 |
| Dec 31, 2017 | -1,801.00 |
| Sep 30, 2017 | 1,298.00 |
| Jun 30, 2017 | -52.00 |
| Mar 31, 2017 | 509.00 |
| Dec 31, 2016 | -995.00 |
| Sep 30, 2016 | 1,684.00 |
| Jun 30, 2016 | -784.00 |
| Mar 31, 2016 | 2,130.00 |
| Dec 31, 2015 | -2,134.00 |
| Sep 30, 2015 | 745.00 |
| Jun 30, 2015 | -433.00 |
| Mar 31, 2015 | 1,739.00 |